Skip to main content
. Author manuscript; available in PMC: 2013 Feb 28.
Published in final edited form as: N Engl J Med. 2003 Jul 17;349(3):247–257. doi: 10.1056/NEJMoa022289

Table 2.

Characteristics of the 570 Patients with Colon Cancer.*

Characteristic All Eligible Patients (N=570) Patients with Tumors Exhibiting High-Frequency Microsatellite Instability (N=95) Patients with Tumors Exhibiting Microsatellite Stability or Low-Frequency Microsatellite Instability (N=475) P Value
Treatment — no. (%) 0.19
 Adjuvant chemotherapy 283 (50) 53 (56) 230 (48)
 No adjuvant chemotherapy 287 (50) 42 (44) 245 (52)

Age — yr 59.8±11.2 60.7±13.0 59.7±10.8 0.13

Sex — no. (%) 0.45
 Male 326 (57) 51 (54) 275 (58)
 Female 244 (43) 44 (46) 200 (42)

Stage of disease — no. (%) 0.18
 II 312 (55) 58 (61) 254 (53)
 III 258 (45) 37 (39) 221 (47)

Site of tumor — no. (%) <0.001
 Proximal 257 (45) 84 (89) 173 (36)
 Distal 305 (54) 9 (10) 296 (62)
 Multiple 6 (1) 1 (1) 5 (1)

Tumor grade — no. (%) <0.001
 Well differentiated (G1) 97 (17) 8 (9) 89 (19)
 Moderately differentiated (G2) 376 (66) 49 (53) 327 (69)
 Poorly differentiated (G3) 65 (11) 24 (26) 41 (9)
 Undifferentiated (G4) 28 (5) 12 (13) 16 (3)

No. of positive nodes — no. (%) 0.21
 0 312 (55) 58 (61) 254 (53)
 1–4 128 (22) 15 (16) 113 (24)
 >4 130 (23) 22 (23) 108 (23)

Vital status at 8 yr — no. (%) 0.03
 Alive 385 (68) 73 (77) 312 (66)
 Dead 185 (32) 22 (23) 163 (34)
*

Plus–minus values are means ± SD. P values for the comparison between patients with tumors exhibiting high-frequency microsatellite instability and patients with tumors exhibiting microsatellite stability or low-frequency microsatellite instability were calculated by the chi-square test for all variables except the mean age at diagnosis, for which an unpaired t-test was used. Because of rounding, not all percentages total 100.

Data pertaining to the site of the tumor and the tumor grade are not available for all 570 patients.